Friday 6 November 2026 Export TFX’s income statement to Excel — free account

Teleflex Incorporated

TFX Healthcare Medical Instruments & Supplies

Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.

Revenue: +28.9%
EPS: −17.3%
Free cash flow: +220.1%
Total debt: +47.7%

Quarter to June 2026, against a year earlier

Dividend growth 25 yrs

152.16 2.29 +1.53%

Follow TFX

Alert me

Market cap: $6.5B
P/E: 0.0×
Fwd P/E: 37.4×
Dividend yield: 0.89%
F-score: 5/9
Altman Z: 2.04
Beneish M: −2.21
Dividend safety: 20/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Teleflex Incorporated 10-Q filed Aug 6, 2026

Fiscal Q2 2026 · Period ended Jun 30, 2026 · Filed Aug 6, 2026 · accepted 3:08 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors, against the 10-Q filed May 7, 2026: no changes; 1 with only figures updated